Letters to the Editor

Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms

Division of Hematology, Mayo Clinic, Rochester, Minnesota
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Haematologica Early view Jan 23, 2025 https://doi.org/10.3324/haematol.2024.287032